Timothy B. Lowinger
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
- Oncology 29
- HER2/EGFR in Cancer Research 19
- Cancer Treatment and Pharmacology 7
- CAR-T cell therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 17
- Radiopharmaceutical Chemistry and Applications 8
- Co-authors
- Roger A. Smith (7 shared papers)Jacques Dumas (6 shared papers)Scott M. Wilhelm (4 shared papers)Christopher Carter (2 shared papers)Brian Schwartz (2 shared papers)Ronit Simantov (2 shared papers)Mark Lynch (2 shared papers)Susan L. Kelley (2 shared papers)
- Journals
- Cancer Research (17 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)The Journal of Organic Chemistry (4 papers)Molecular Cancer Therapeutics (2 papers)Nature Reviews Drug Discovery (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Timothy B. Lowinger
48 papers receiving 2.6k citations
Timothy B. Lowinger's Hit Papers
Peers
Comparison fields: 5 of 110
- Hepatology 257
- Cancer Research 475
- Oncology 843
- Organic Chemistry 742
- Molecular Biology 1.3k
Countries citing papers authored by Timothy B. Lowinger
This map shows the geographic impact of Timothy B. Lowinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy B. Lowinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy B. Lowinger more than expected).
Fields of papers citing papers by Timothy B. Lowinger
This network shows the impact of papers produced by Timothy B. Lowinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy B. Lowinger. The network helps show where Timothy B. Lowinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy B. Lowinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery and development of sorafenib: a multikinase inhibitor for treating cancer Hit paper breakdown → | 2006 | 1447 |
| 2 | 2003 | 150 | |
| 3 | 2005 | 125 | |
| 4 | 2002 | 118 | |
| 5 | 2004 | 101 | |
| 6 | 2017 | 98 | |
| 7 | 2015 | 73 | |
| 8 | 2001 | 70 | |
| 9 | 2004 | 59 | |
| 10 | 2000 | 47 | |
| 11 | 2000 | 34 | |
| 12 | 2024 | 33 | |
| 13 | 2023 | 32 | |
| 14 | Recent developments in the discovery of protein kinase inhibitors from the urea class. | 2004 | 31 |
| 15 | 1992 | 30 | |
| 16 | 2005 | 30 | |
| 17 | 2012 | 29 | |
| 18 | 1995 | 29 | |
| 19 | 1996 | 27 | |
| 20 | 1992 | 20 |
About Timothy B. Lowinger
Timothy B. Lowinger is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Organic Chemistry and Immunology, having authored 53 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Cancer Treatment and Pharmacology (7 papers), Melanoma and MAPK Pathways (5 papers), NF-κB Signaling Pathways (5 papers), Synthesis and biological activity (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hepatology (257 citations), Cancer Research (475 citations), Oncology (843 citations), Organic Chemistry (742 citations) and Molecular Biology (1.3k citations). Timothy B. Lowinger has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Roger A. Smith, Jacques Dumas, Scott M. Wilhelm, Christopher Carter, Brian Schwartz, Ronit Simantov, Mark Lynch, Susan L. Kelley, Bernd Riedl and Gene M. Dubowchik. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Molecular Cancer Therapeutics and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.